Luo et al. (2018) found that liver tissues from patients with non‐alcoholic fatty liver disease and mice with HFD‐induced steatosis expressed higher levels of STING, while STING inhibition in macrophages decreased the inflammation and the severity of the liver fibrosis. This evidence concerns the gene STING1 and steatosis.